1-15 of 15
David M. Harlan
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

The Noble and Often Nobel Role Played by Insulin-Focused Research in Modern Medicine

Victor S. Harrison, Mahfuzul H. Khan, Christine E. Chamberlain, David M. Harlan
Journal: Diabetes Care
Diabetes Care 2022;45(1):23–27
https://doi.org/10.2337/dci21-0012
Published: 28 December 2021
View article titled, The Noble and Often Nobel Role Played by Insulin-Focused Research in Modern Medicine
Open the PDF for The Noble and Often Nobel Role Played by Insulin-Focused Research in Modern Medicine in another window
Journal Articles

State of Behavioral Health Integration in U.S. Diabetes Care: How Close Are We to ADA Recommendations?

Samantha A. Barry, David M. Harlan, Nicole L. Johnson, Kristin L. MacGregor
Journal: Diabetes Care
Diabetes Care 2018;41(7):e115–e116
https://doi.org/10.2337/dc18-0642
Published: 30 April 2018
View article titled, State of Behavioral Health Integration in U.S. Diabetes Care: How Close Are We to ADA Recommendations?
Open the PDF for State of Behavioral Health Integration in U.S. Diabetes Care: How Close Are We to ADA Recommendations? in another window
Journal Articles

Response to Comment on Harlan. Islet Transplantation for Hypoglycemia Unawareness/Severe Hypoglycemia: Caveat Emptor. Diabetes Care 2016;39:1072–1074

David M. Harlan
Journal: Diabetes Care
Diabetes Care 2017;40(8):e113–e114
https://doi.org/10.2337/dci17-0013
Published: 11 July 2017
View article titled, Response to Comment on Harlan. Islet Transplantation for Hypoglycemia Unawareness/Severe Hypoglycemia: Caveat Emptor. Diabetes Care 2016;39:1072–1074
Open the PDF for Response to Comment on Harlan. Islet Transplantation for Hypoglycemia Unawareness/Severe Hypoglycemia: Caveat Emptor. Diabetes Care 2016;39:1072–1074 in another window
Journal Articles

Exenatide Improves HDL Particle Counts and Size Distribution in Patients With Long-standing Type 1 Diabetes

Evgenia A. Gourgari, Mihriye Mete, Maureen L. Sampson, David M. Harlan, Alan T. Remaley, Kristina I. Rother
Journal: Diabetes Care
Diabetes Care 2017;40(7):e88–e89
https://doi.org/10.2337/dc16-2602
Published: 13 June 2017
View article titled, Exenatide Improves HDL Particle Counts and Size Distribution in Patients With Long-standing Type 1 Diabetes
Open the PDF for Exenatide Improves HDL Particle Counts and Size Distribution in Patients With Long-standing Type 1 Diabetes in another window
Journal Articles

Islet Transplantation for Hypoglycemia Unawareness/Severe Hypoglycemia: Caveat Emptor

David M. Harlan
Journal: Diabetes Care
Diabetes Care 2016;39(7):1072–1074
https://doi.org/10.2337/dci16-0008
Published: 09 June 2016
View article titled, Islet Transplantation for Hypoglycemia Unawareness/Severe Hypoglycemia: Caveat Emptor
Open the PDF for Islet Transplantation for Hypoglycemia Unawareness/Severe Hypoglycemia: Caveat Emptor in another window
Journal Articles

Response to Comment on Sarkar et al. Exenatide Treatment for 6 Months Improves Insulin Sensitivity in Adults With Type 1 Diabetes. Diabetes Care 2014;37:666–670

Gayatri Sarkar, May Alattar, Rebecca J. Brown, Michael J. Quon, David M. Harlan, Kristina I. Rother
Journal: Diabetes Care
Diabetes Care 2014;37(10):e219–e220
https://doi.org/10.2337/dc14-1482
Published: 10 September 2014
View article titled, Response to Comment on Sarkar et al. Exenatide Treatment for 6 Months Improves Insulin Sensitivity in Adults With Type 1 Diabetes. Diabetes Care 2014;37:666–670
Open the PDF for Response to Comment on Sarkar et al. Exenatide Treatment for 6 Months Improves Insulin Sensitivity in Adults With Type 1 Diabetes. Diabetes Care 2014;37:666–670 in another window
Journal Articles

Exenatide Treatment for 6 Months Improves Insulin Sensitivity in Adults With Type 1 Diabetes

Gayatri Sarkar, May Alattar, Rebecca J. Brown, Michael J. Quon, David M. Harlan, Kristina I. Rother
Journal: Diabetes Care
Diabetes Care 2014;37(3):666–670
https://doi.org/10.2337/dc13-1473
Published: 11 February 2014
View article titled, Exenatide Treatment for 6 Months Improves Insulin Sensitivity in Adults With Type 1 Diabetes
Open the PDF for Exenatide Treatment for 6 Months Improves Insulin Sensitivity in Adults With Type 1 Diabetes in another window
Includes: Supplementary data
Journal Articles

Differences in the Management of Type 1 Diabetes Among Adults Under Excellent Control Compared With Those Under Poor Control in the T1D Exchange Clinic Registry

Jill H. Simmons, MD, Vincent Chen, PHD, Kellee M. Miller, MPH, Janet B. McGill, MD, Richard M. Bergenstal, MD, Robin S. Goland, MD, David M. Harlan, MD, Joseph F. Largay, PA, Elaine M. Massaro, MS, Roy W. Beck, MD, for the T1D Exchange Clinic Network
Journal: Diabetes Care
Diabetes Care 2013;36(11):3573–3577
https://doi.org/10.2337/dc12-2643
Published: 15 October 2013
View article titled, Differences in the Management of Type 1 Diabetes Among Adults Under Excellent Control Compared With Those Under Poor Control in the T1D Exchange Clinic Registry
Open the PDF for Differences in the Management of Type 1 Diabetes Among Adults Under Excellent Control Compared With Those Under Poor Control in the T1D Exchange Clinic Registry in another window
Includes: Supplementary data
Journal Articles

Diabetes and Cancer: A consensus report

Edward Giovannucci, MD, SCD, David M. Harlan, MD, Michael C. Archer, MA, PHD, DSC, Richard M. Bergenstal, MD, Susan M. Gapstur, PHD, Laurel A. Habel, PHD, Michael Pollak, MD, Judith G. Regensteiner, PHD, Douglas Yee, MD
Journal: Diabetes Care
Diabetes Care 2010;33(7):1674–1685
https://doi.org/10.2337/dc10-0666
Published: 01 July 2010
View article titled, Diabetes and Cancer: <subtitle>A consensus report</subtitle>
Open the PDF for Diabetes and Cancer: <subtitle>A consensus report</subtitle> in another window
Journal Articles

Effects of Exenatide Alone and in Combination With Daclizumab on β-Cell Function in Long-Standing Type 1 Diabetes

Kristina I. Rother, MD, MHSC, Lisa M. Spain, PHD, Robert A. Wesley, PHD, Benigno J. Digon, III, MD, Alain Baron, MD, Kim Chen, PHD, Patric Nelson, MPH, H.-Michael Dosch, MD, Jerry P. Palmer, MD, Barbara Brooks-Worrell, PHD, Michael Ring, MD, David M. Harlan, MD
Journal: Diabetes Care
Diabetes Care 2009;32(12):2251–2257
https://doi.org/10.2337/dc09-0773
Published: 06 October 2009
View article titled, Effects of Exenatide Alone and in Combination With Daclizumab on β-Cell Function in Long-Standing Type 1 Diabetes
Open the PDF for Effects of Exenatide Alone and in Combination With Daclizumab on β-Cell Function in Long-Standing Type 1 Diabetes in another window
Journal Articles

Counterpoint: Clinical Islet Transplantation: Not Ready for Prime Time

Mahfuzul H. Khan, MD, David M. Harlan, MD
Journal: Diabetes Care
Diabetes Care 2009;32(8):1570–1574
https://doi.org/10.2337/dc09-0611
Published: 01 August 2009
View article titled, Counterpoint: Clinical Islet Transplantation: Not Ready for Prime Time
Open the PDF for Counterpoint: Clinical Islet Transplantation: Not Ready for Prime Time in another window
Journal Articles

Effect of Ingested Interferon-α on β-Cell Function in Children With New-Onset Type 1 Diabetes

Kristina I. Rother, MD, MHSC, Rebecca J. Brown, MD, Miriam M. Morales, BS, Elizabeth Wright, PHD, MPH, Zhigang Duan, MS, Carol Campbell, CRNP, Dana S. Hardin, MD, Jadranka Popovic, MD, Robert C. McEvoy, MD, David M. Harlan, MD, Philip R. Orlander, MD, Staley A. Brod, MD
Journal: Diabetes Care
Diabetes Care 2009;32(7):1250–1255
https://doi.org/10.2337/dc08-2029
Published: 01 July 2009
View article titled, Effect of Ingested Interferon-α on β-Cell Function in Children With New-Onset Type 1 Diabetes
Open the PDF for Effect of Ingested Interferon-α on β-Cell Function in Children With New-Onset Type 1 Diabetes in another window
Includes: Supplementary data
Journal Articles

Benefits and Risks of Solitary Islet Transplantation for Type 1 Diabetes Using Steroid-Sparing Immunosuppression : Response to Charles and Selam

Boaz Hirshberg, MD, Kristina I. Rother, MD, Benigno J. Digon, III, MD, David M. Harlan, MD
Journal: Diabetes Care
Diabetes Care 2004;27(5):1250–1251
https://doi.org/10.2337/diacare.27.5.1250
Published: 01 May 2004
View article titled, Benefits and Risks of Solitary Islet Transplantation for Type 1 Diabetes Using Steroid-Sparing Immunosuppression : <subtitle>Response to Charles and Selam</subtitle>
Open the PDF for Benefits and Risks of Solitary Islet Transplantation for Type 1 Diabetes Using Steroid-Sparing Immunosuppression : <subtitle>Response to Charles and Selam</subtitle> in another window
Journal Articles

Benefits and Risks of Solitary Islet Transplantation for Type 1 Diabetes Using Steroid-Sparing Immunosuppression: The National Institutes of Health experience

Boaz Hirshberg, MD, Kristina I. Rother, MD, Benigno J. Digon, III, MD, Janet Lee, MD, Jason L. Gaglia, MD, Kenneth Hines, BS, MT (ASCP), Elizabeth J. Read, MD, Richard Chang, MD, Bradford J. Wood, MD, David M. Harlan, MD
Journal: Diabetes Care
Diabetes Care 2003;26(12):3288–3295
https://doi.org/10.2337/diacare.26.12.3288
Published: 01 December 2003
View article titled, Benefits and Risks of Solitary Islet Transplantation for Type 1 Diabetes Using Steroid-Sparing Immunosuppression: <subtitle>The National Institutes of Health experience </subtitle>
Open the PDF for Benefits and Risks of Solitary Islet Transplantation for Type 1 Diabetes Using Steroid-Sparing Immunosuppression: <subtitle>The National Institutes of Health experience </subtitle> in another window
Journal Articles

Sirolimus-Induced Interstitial Pneumonitis in an Islet Transplant Recipient

Benigno J. Digon, III, MD, Kristina I. Rother, MD, Boaz Hirshberg, MD, David M. Harlan, MD
Journal: Diabetes Care
Diabetes Care 2003;26(11):3191
https://doi.org/10.2337/diacare.26.11.3191
Published: 01 November 2003
View article titled, Sirolimus-Induced Interstitial Pneumonitis in an Islet Transplant Recipient
Open the PDF for Sirolimus-Induced Interstitial Pneumonitis in an Islet Transplant Recipient in another window